Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. ENOV
6. AON
7. AZN
8. AAPL
9. BLSM
10. GPRO

Go back to Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) Delayed: 14.90 +0.12 (0.81%)
Previous Close $14.78    52 Week High $19.40 
Open $15.04    52 Week Low $12.50 
Day High $15.04    P/E N/A 
Day Low $14.88    EPS $0.00 
Volume 47,577